Ultragenyx Pharmaceutical Inc.

RARE | NASDAQ

Price Alert Chart Builder DCF Calculator

$15.96

+$1.31 (+8.94%)

Sep 22, 2026, 12:51 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-575M	-569.18M	-606.64M	-707.42M	-454.03M	-186.57M
Depreciation & Amortization	35M	35.54M	26.01M	18.22M	13.24M	12.26M
Stock-Based Compensation	153M	158.03M	135.21M	130.38M	104.95M	85.74M
Other Working Capital	-10M	11.73M	12.23M	2.16M	-57.49M	66.57M
Other Non-Cash Items	-56M	-52.5M	-12.67M	118.12M	11.71M	21.46M
Deferred Income Tax	n/a	n/a	-1.62M	n/a	48.67M	-169.78M
Change in Working Capital	-23M	13.92M	-15.1M	60.24M	-63.24M	104.66M
Operating Cash Flow	-466M	-414.19M	-474.81M	-380.47M	-338.7M	-132.22M
Capital Expenditures	-6M	-7.49M	-46.77M	-146.12M	-73.09M	-43.91M
Cash Acquisitions	n/a	n/a	n/a	-75.03M	n/a	n/a
Purchase of Investments	-186M	-408.61M	-526.38M	-614.74M	-1.01B	-850.3M
Sales Maturities Of Investments	444M	413.27M	746.2M	545.08M	890.85M	720.64M
Other Investing Acitivies	-16M	-14.94M	-7.55M	-30.84M	-942K	-5.56M
Investing Cash Flow	236M	-17.77M	168M	-291.65M	-195.37M	-179.12M
Debt Repayment	392M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	18.26M	8.39M	501.21M	39.61M	89.06M
Financial Cash Flow	478M	399.24M	388.14M	501.21M	118.55M	600.27M
Net Cash Flow	253.47M	-35.24M	81.8M	-171.98M	-416.71M	290.05M
Free Cash Flow	-472M	-421.68M	-521.57M	-526.59M	-411.79M	-176.13M
Adj. Free Cash Flow	-625M	-579.71M	-656.79M	-656.97M	-516.74M	-261.86M
Maintenance CapEx	n/a	n/a	-3.75M	-139M	-28.68M	n/a
Growth CapEx	-6M	-7.49M	-43.02M	-7.13M	-44.41M	-43.91M
Owner Earnings	-466M	-414.19M	-478.56M	-519.46M	-367.38M	-132.22M